









市場行情
/
股票
/
nasdaq-rxst
/

Rxsight Inc

RXST

10.930USD

-0.530-4.62%

收盤 12/26, 16:00（美東）報價延遲15分鐘

449.02M總市值

虧損本益比TTM



Rxsight Inc

10.930

-0.530-4.62%

概覽公司財務分析

概覽

公司

財務

分析

關於 Rxsight Inc 公司

RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Rxsight Inc簡介



公司代碼RXST

公司名稱Rxsight Inc

上市日期Jul 30, 2021

CEOKurtz (Ron M)

員工數量498

證券類型Ordinary Share

年結日Jul 30

公司地址100 Columbia Street

城市ALISO VIEJO

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編92656

電話19495217822

網址https://www.rxsight.com/

公司代碼RXST

上市日期Jul 30, 2021

CEOKurtz (Ron M)

Rxsight Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Eric Weinberg

Co-President, Chief Commercial Officer

496.25K

+60.99%

Dr. Ilya Goldshleger, Ph.D.

Co-President, Chief Operating Officer

67.06K

+53.75%

Dr. William J. Link, Ph.D.

Independent Director

59.10K

+22.24%

Mr. Robert J. (Bob) Palmisano

Independent Director

41.04K

+35.50%

Ms. Shelley B. Thunen

Co-President, Chief Financial Officer

38.35K

-1.26%

Ms. Shweta Singh Maniar

Independent Director

18.14K

+145.63%

Dr. Ron M. Kurtz, M.D.

President, Chief Executive Officer, Director

Ms. Juliet Tammenoms Bakker

Independent Director

Mr. J. Andy Corley

Independent Chairman of the Board

Ms. Julie B. Andrews

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Eric Weinberg

Co-President, Chief Commercial Officer

496.25K

+60.99%

Dr. Ilya Goldshleger, Ph.D.

Co-President, Chief Operating Officer

67.06K

+53.75%

Dr. William J. Link, Ph.D.

Independent Director

59.10K

+22.24%

Mr. Robert J. (Bob) Palmisano

Independent Director

41.04K

+35.50%

Ms. Shelley B. Thunen

Co-President, Chief Financial Officer

38.35K

-1.26%

Ms. Shweta Singh Maniar

Independent Director

18.14K

+145.63%

收入明細

FY2024

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

139.93M

0.00%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

5.47%

Millennium Management LLC

5.33%

The Vanguard Group, Inc.

5.22%

D. E. Shaw & Co., L.P.

4.46%

Artisan Partners Limited Partnership

4.27%

其他

75.25%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

5.47%

Millennium Management LLC

5.33%

The Vanguard Group, Inc.

5.22%

D. E. Shaw & Co., L.P.

4.46%

Artisan Partners Limited Partnership

4.27%

其他

75.25%

股東類型

持股股東

佔比

Investment Advisor

34.73%

Hedge Fund

24.74%

Investment Advisor/Hedge Fund

13.27%

Research Firm

7.17%

Individual Investor

5.59%

Pension Fund

1.07%

Private Equity

0.56%

Bank and Trust

0.28%

Family Office

0.06%

其他

12.53%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

449

38.67M

94.05%

-9.26M

2025Q2

446

40.83M

100.45%

-3.67M

2025Q1

453

40.49M

99.79%

-7.96M

2024Q4

440

38.96M

96.23%

-5.07M

2024Q3

420

38.15M

94.75%

-3.92M

2024Q2

391

37.00M

93.42%

-2.64M

2024Q1

338

34.63M

93.15%

-2.60M

2023Q4

299

33.17M

91.51%

-284.01K

2023Q3

253

34.41M

96.36%

-1.84M

2023Q2

214

31.39M

90.12%

+2.22M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

2.51M

6.13%

-48.31K

-1.89%

Jun 30, 2025

Millennium Management LLC

2.61M

6.38%

+1.66M

+174.50%

Jul 09, 2025

The Vanguard Group, Inc.

2.27M

5.55%

-113.59K

-4.76%

Jun 30, 2025

D. E. Shaw & Co., L.P.

1.32M

3.23%

+1.30M

+5906.05%

Jun 30, 2025

Artisan Partners Limited Partnership

2.25M

5.51%

+485.02K

+27.44%

Jun 30, 2025

NO STREET GP LP

1.20M

2.93%

+600.00K

+100.00%

Jun 30, 2025

Two Sigma Investments, LP

621.86K

1.52%

+408.47K

+191.42%

Jun 30, 2025

Citadel Advisors LLC

1.03M

2.51%

+797.64K

+346.47%

Jun 30, 2025

DWS Investments UK Limited

1.22M

2.99%

+566.62K

+86.54%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

State Street SPDR S&P Health Care Equipment ETF

0.62%

ProShares Hedge Replication ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

iShares Morningstar Small-Cap Value ETF

0.01%

iShares Russell 2000 ETF

0.01%

WisdomTree US SmallCap Fund

0.01%

Schwab U.S. Small-Cap ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Global X Russell 2000 ETF

0.01%

Proshares Ultra Russell 2000

0.01%

State Street SPDR S&P Health Care Equipment ETF

佔比0.62%

ProShares Hedge Replication ETF

佔比0.02%

iShares Russell 2000 Growth ETF

佔比0.02%

iShares Morningstar Small-Cap Value ETF

佔比0.01%

iShares Russell 2000 ETF

佔比0.01%

WisdomTree US SmallCap Fund

佔比0.01%

Schwab U.S. Small-Cap ETF

佔比0.01%

ProShares UltraPro Russell2000

佔比0.01%

Global X Russell 2000 ETF

佔比0.01%

Proshares Ultra Russell 2000

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Rxsight Inc的前五大股東是誰？



Rxsight Inc的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：2.51M
佔總股份比例：6.13%。
Millennium Management LLC
持有股份：2.61M
佔總股份比例：6.38%。
The Vanguard Group, Inc.
持有股份：2.27M
佔總股份比例：5.55%。
D. E. Shaw & Co., L.P.
持有股份：1.32M
佔總股份比例：3.23%。
Artisan Partners Limited Partnership
持有股份：2.25M
佔總股份比例：5.51%。